The U.S. Food and Drug Administration (FDA) recently released a digital Health and Artificial Intelligence Glossary “to help support consistent use of digital health and artificial intelligence terminology by the FDA and interested parties (such as industry, digital health developers, …
FDA Digital Health and Artificial Intelligence Glossary Read more »
The U.S. Department of Health and Human Services (HHS) recently announced every U.S. household is again eligible to order free covid-19 at-home rapid antigen tests, by visiting the COVIDTests.gov website. There is a limit of one order per residential address, …
Free COVID-19 Rapid Antigen Tests Available Again Read more »
The U.S. Food and Drug Administration (FDA) recently released the FDA Language Access Plan 2024. The Plan “outlines the action steps the agency will take to meet the language access needs of the communities FDA serves while continuing to support …
The U.S. Food and Drug Administration (FDA) recently issued “Diversity Action Plans to Improved Enrollment of Participants from Underrepresented Populations in Clinical Studies.” This draft guidance “describes the form, content, and manner of diversity action plans, the applicable medical products, …
The U.S. Department of Justice (DOJ) Drug Enforcement Administration (DEA) recently announced it is proposing a rule to transfer marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). [See 21 U.S.C. § 812 Schedules of controlled …
DEA Proposes Transferring Marijuana to Schedule III Read more »
